Orchid Pharma Q2 Results
- BSE: 524372
- NSE: ORCHPHARMA
- ISIN: INE191A01027
- Sector: Biotechnology & Drugs
BSE
1,012.45
-21.55 (-2.08%)
-21.55 (-2.08%)Volume3.58 K
Updated: Thu 18 Jun, 2026 | 12:48:47
NSE
1,017.95-18.90 (-1.82%)
-18.90 (-1.82%)Volume45.77 K
Updated: Thu 18 Jun, 2026 | 12:33:17
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Orchid Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 203.90 | 167.41 | 21.80% | 200.99 | 1.45% |
| Depreciation/ Amortization | 8.90 | 8.65 | 2.86% | 8.63 | 3.20% |
| Operating Income | -10.38 | 5.52 | 0.00% | 21.71 | 0.00% |
| Net Income | -5.72 | 14.91 | 0.00% | 27.24 | 0.00% |
| Other Operating Expenses Total | 37.64 | 38.28 | -1.65% | 41.14 | -8.50% |
| Net Income Before Taxes | -3.33 | 13.71 | 0.00% | 25.90 | 0.00% |
| Total Revenue | 193.52 | 172.93 | 11.91% | 222.70 | -13.10% |
| Selling/ General/ Admin Expenses Total | 24.85 | 21.61 | 14.98% | 20.06 | 23.89% |
| Diluted Normalized EPS | -1.13 | 2.94 | 0.00% | 5.37 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.